<DOC>
	<DOCNO>NCT01484652</DOCNO>
	<brief_summary>The primary objective study show effectiveness repeat dos COV795 versus placebo , use sum pain intensity difference first 48 hour subject acute moderate severe pain follow bunionectomy .</brief_summary>
	<brief_title>Safety Efficacy COV795 Moderate Severe Post-Operative Bunionectomy Pain With Open-label Extension</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<criteria>Inclusion Criteria 1 . Complete inform consent process document sign informed consent form ( ) . 2 . Be generally good health . 3 . Be 18 75 year age , inclusively time screen . 4 . Be schedule primary unilateral first metatarsal bunionectomy ( collateral procedure ) . 5 . Have body mass index â‰¤33 kg/m2 . 6 . Female subject eligible pregnant , lactating , plan become pregnant duration study , surgically sterile least two year postmenopausal , practice acceptable form birth control least 2 month 7 . Male subject must sterile commit use reliable method birth control 8 . Be classified Physical status 1 ( PS1 ) PS2 American Society Anesthetists ( ASA ) Physical Status Classification System . 9 . Be willing complete pain evaluation return clinic schedule . Exclusion Criteria 1 . Have uncontrolled medical condition , serious intercurrent illness , clinically significant general health condition , extenuate circumstance may significantly decrease study compliance otherwise preclude participation study . 2 . Have clinically significant abnormal electrocardiogram ( ECG ) screen 3 . Have type gastric bypass surgery gastric band . 4 . Have previous abdominal surgery within past year history abdominal adhesion , know suspect paralytic ileus . 5 . Have history medical condition would alter absorption , distribution , metabolism excretion COV795 6 . Have history severe bronchial asthma , hypercarbia , hypoxia 7 . Have clinically significant abnormality clinical laboratory value 8 . Have Addison 's disease , benign prostatic hyperplasia , kidney disease 9 . Have donate blood blood component within 3 month prior screen visit . 10 . Have know allergy hypersensitivity opioid analgesic , anesthetic , acetaminophen , Nonsteroid antiinflammatory drug ( NSAIDs ) . 11 . Have history intolerance short term opioid use . 12 . Unwilling discontinue certain prohibited medication within allotted time surgery throughout duration study . Have take certain drug within indicate time surgery . 13 . Have history substance alcohol abuse and/or positive result drug screening . 14 . Have positive test human immunodeficiency virus ( HIV ) , hepatitis B virus ( HBV ) , hepatitis C virus ( HCV ) screen visit . 15 . Have dysphagia and/or swallow study medication whole . 16 . Have history migraine frequent headache , seizure , currently take anticonvulsant . 17 . Have previously participate clinical trial use COV795 bunionectomy last 3 month . 18 . Received investigational drug device within 4 week prior screen visit . 19 . Other criterion specify trial protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Moderate Post-Operative Pain</keyword>
	<keyword>Severe Post-Operative Pain</keyword>
	<keyword>Bunionectomy</keyword>
</DOC>